Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 95, Issue 8, Pages 1783-1799Publisher
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.20481
Keywords
allometric scaling; vertical allometry; clearance; protein binding; C logP
Ask authors/readers for more resources
Allometrically scaled data sets (138 compounds) used for predicting human clearance were obtained from the literature. Our analyses of these data have led to four observations. (1) The current data do not provide strong evidence that systemic clearance (CLs; n = 102) is more predictable than apparent oral clearance (CLpo; n = 24), but caution needs to be applied because of potential CLpo prediction error caused by differences in bioavailability across species. (2) CL, of proteins (n = 10) can be more accurately predicted than that of non-protein chemicals (n = 102). (3) CL, is more predictable for compounds eliminated by renal or biliary excretion (n = 33) than by metabolism (n = 57). (4) CL predictability for hepatically eliminated compounds followed the order: high CL (n = 11) > intermediate CL (n = 17) > low CL (n = 29). All examples of large vertical allometry (% error of prediction greater than 1000%) occurred only when predicting human CLs of drugs having very low CLs. A qualitative analysis revealed the application of two potential rules for predicting the occurrence of large vertical allometry: (1) ratio of unbound fraction of drug in plasma (f(u)) between rats and humans greater than 5; (2) C logP greater than 2. Metabolic elimination could also serve as an additional indicator for expecting large vertical allometry. (c) 2006 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available